Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in humans, due to late diagnosis and limited treatment possibilities. Improved treatment for PDAC patients is warranted. Cyclin-dependent kinase 1 (CDK1) is a stimulator of cell cycle progression and its activi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijnen, Rosa, Pecoraro, Camilla, Carbone, Daniela, Fiuji, Hamid, Avan, Amir, Peters, Godefridus J., Giovannetti, Elisa, Diana, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430873/
https://www.ncbi.nlm.nih.gov/pubmed/34503199
http://dx.doi.org/10.3390/cancers13174389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430873/
https://www.ncbi.nlm.nih.gov/pubmed/34503199
http://dx.doi.org/10.3390/cancers13174389

Ejemplares similares